Jump to content
IndiaDivine.org

Polyheme experiments...beware

Rate this topic


Guest guest

Recommended Posts

I've been watching this for the past year or so since I first heard about it. Polyheme is an experimental blood substitute, being used without consent on people involved in car accidents etc. The only way to not be included in this experiment is an "opt out" system which many are not aware of in their communities. At least that's how it started. Meetings were anounced in the communities where this was being used, for people to opt out of this and a wrist band was being recommended to be worn by those opting out......there's been problems with this experimental blood as well as the lack of informed consent issue....see below.

ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Promoting Openness, Full Disclosure, and Accountability http://www.ahrp.org

FYI

From messages received, I gather that many of you missed the CNN-Paula Zahn News segment about FDA's controversial approval of a commercially sponsored experiment on trauma patients in 38 American urban centers. [1]

The video of the segment with Dr. Sanje Gupta is posted at CNN--however, you must first get past a commercial for cereal....:

http://www.emailthis.clickability.com/et/emailThis?clickMap=viewThis & etMailToID=397205794

The experiment tested the artificial blood product, PolyHeme, manufactured by Northfield Laboratories, without the informed consent of the subjects. The FDA violated its own standards for "waived consent" research--which is applicable only if there are no alternatives. However, blood is the universally acknowledged safe and effective standard of treatment available in urban centers.

In a previous experiment on surgery patients who gave consent, 10 of 81 people who received PolyHeme suffered heart attacks, 2 died. None suffered heart attacks in 71 patients who received real human blood.

The trauma patients in the communities in which the expeirment was conducted were actually denied the benefit of life-saving real blood. Their lives were put at increased risk of death--in order to test whether an anrtificial blood product could be substituted. The experiment is an obvious commercially driven test.

The CNN report presents both sides of the debate: Sara Goodkind, the FDA official who defends the experiment claiming there are "no good alternatives"--given that human blood is safe and effective, the argument is disingenuous.

Joining me in the critic's corner is Dr. Robert Klitman, a bioethicist at Columbia University. Also presented is a single patient who survived treatment with PolyHeme who believes that that the product saved her life. However, the "belief" of an individual is not science-based evidence. The issue is whether the artificial product is as safe as human blood.

The video of the segment with Dr. Sanje Gupta is posted at CNN--you must get past a commercial for cereal....:

http://www.emailthis.clickability.com/et/emailThis?clickMap=viewThis & etMailToID=397205794

In this brief news report, CNN did not include mention of the blistering letter by Senator Charles Grassley to the Secretary of Health and Human Services about the complicity of the FDA and Northfield Laboratories in the approval of this experiment and the deception of the communities in which it was conducted. [2]

“I am personally troubled that, for all intents and purposes, the FDA allowed a clinical trial to proceed, which makes the inhabitants of 32 communities in 18 states, and anyone living or traveling near these communities, potential “guinea pigs,” without their consent and, absent consent, without full awareness of the risks and benefits of the blood substitute.”

Sen. Grassley informs the Secretary that the senior officials of the Office of Human Research Protections (OHRP), wrote (then) FDA commissioner several times expressing their concerns. OHRP officials informed the Senator and his staff at a meeting that “OHRP would not have approved the PolyHeme Study because its design and implementation remains unethical.”

 

See:

 

1. On March 2, 2006, AHRP filed a complaint with the federal Office of Human Research Protections--correspondence is posted at: www.ahrp.org/cms/content/view/91/180

2. See Sen. Grassley letter, March 14, 2006 : http://www.ahrp.org/cms/content/view/108/27/

Contact: Vera Hassner Sharav 212-595-8974 veracare

 

Video: Waived consent controversy

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Powered by

 

 

* Please note, the sender's email address has not been verified.

 

 

 

 

 

 

 

 

 

 

 

You look great!

 

 

 

 

 

 

 

 

 

 

 

Click the following to access the sent link:

 

 

 

 

 

 

 

 

 

Video: Waived consent controversy*

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Get your EMAIL THIS Browser Button and use it to email information from any Web site.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

*This article can also be accessed if you copy and paste the entire address below into your web browser.http://www.cnn.com/video/partners/clickability/index.html?url=/video/health/2006/11/16/gupta.waived.consent.cnn

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...